Consider your medical history BMI and Comorbidities: GLP-1 agonists: Weight loss medications are an approved treatment for people with a Body Mass Index (BMI) over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea
Kahal, H., Kilpatrick, E., Rigby, A., Coady, A
Initially approved for glycemic control in type 2 diabetes mellitus, their clinical application has expanded into obesity management, cardiovascular risk reduction, and metabolic syndrome modulation
Sometimes yes for diabetes, often no for weight management
During this first month, focus on maintaining the healthy eating patterns you established on medication and begin taking a prenatal vitamin with 400-800mcg folate daily
Garvey WT (2021) Long-term health benefits of intensive lifestyle intervention in the Look AHEAD study